The unavailability of appropriate pediatric drug pack size is a global issue. Antibiotics are the lifesaving and most frequently prescribed therapeutic agents given to pediatrics. The objective of this study was to assess the compliance of pediatric antibiotic pack size with the standard dosage regimen.
Methods:
A descriptive study design was employed. Data were collected from a community pharmacy in Bahawalpur, Pakistan, between August 1, 2017, and September 30, 2017. Five most commonly prescribed antibiotics were selected and calculations were made to check the appropriateness of packaging size by comparing the quantity of product in the available pack with the dosage regimen recommended by the British National Formulary for Children (BNFC).
Results:
Only 16 clarithromycin, 9 amoxicillin, 1 cefotaxime, and 1 metronidazole packaging sizes were sufficient to meet the dosage regimen for treatment. None of the available pack sizes for gentamicin matched the recommended duration of treatment. The study findings revealed that the available pack sizes either had leftover or a shortfall of antibiotic formulation. Highly inappropriate dosage forms (containing either excess and less quantity) of antibiotics were intravenous infusions and oral suspensions.
Conclusion:
The study concluded that the packaging sizes of antibiotics failed to supply the recommended dosage regimen to pediatrics for common indications. This may contribute to development of antibiotic resistance among pediatric patients. Health policy makers should devise strict rules and regulations to ensure the availability of child-specific antibiotic pack sizes.
World Health Organization. Promoting Safety of Medicines for Children. Geneva: World Health Organization; 2007.
2.
NunnTWilliamsJ. Formulation of medicines for children. Br J Clin Pharmacol. 2005;59(6):674–676.
3.
IvanovskaVRademakerCMvan DijkLMantel-TeeuwisseAK. Pediatric drug formulations: a review of challenges and progress. Pediatr. 2014;134(2):361–372.
4.
European Medicines Agency. Guidelines on Pharmaceutical development of Medicines for Paediatric Use. 2013.
5.
Le DoareKBarkerCISSharlandAIM. Improving antibiotic prescribing for children in the resource-poor setting. Br J Clin Pharmacol. 2015;79(3):446–455.
6.
HoppuKRanganathanSSDodooAN. Realities of paediatric pharmacotherapy in the developing world. Arch Dis Child. 2011;96(8):764–768.
7.
StandingJFTuleuC. Paediatric formulations—getting to the heart of the problem. Int J Pharm. 2005;300(1-2):56–66.
8.
McGuireTMSmithJDel MarC. The match between common antibiotics packaging and guidelines for their use in Australia. Aust N Z J Public Health. 2015;39(6):569–572.
9.
KaplanWMathersC. The World Medicines Situation2011. Geneva: World Health Organization; 2011.
10.
RogawskiETPlatts-MillsJASeidmanJC. Use of antibiotics in children younger than two years in eight countries: a prospective cohort study. Bull World Health Organ. 2017;95(1):49.
11.
SchirmETobiHde VriesTWChoonaraIDeJong-van den Berg LT. Lack of appropriate formulations of medicines for children in the community. Acta Paediatr. 2003;92(12):1486–1489.
12.
Ekins-DaukesSMcLayJSTaylorMWSimpsonCRHelmsPJ. Antibiotic prescribing for children. Too much and too little? Retrospective observational study in primary care. Br J Clin Pharmacol. 2003;56(1):92–95.
13.
FredericksIHollingworthSPudmenzkyARossatoLKairuzT. “Repeat” prescriptions and antibiotic resistance: findings from Australian community pharmacy. Int J Pharm Pract. 2017;25(1):50–58.
14.
NaikPPMehtaCDSrivastavaSK. Analysis of commonly used pediatric systemic antibacterial liquid formulations for rational drug therapy. Natl J Physiol Pharm Pharmacol. 2017;7(4):348.
15.
BenjaminLFrushKShawK. Pediatric medication safety in the emergency department. Pediatrics. 2018;141(3):e20174066.
16.
GirmaSSisayMMengistuGAmareFEdessaD. Antimicrobial utilization pattern in pediatric patients in tertiary care hospital, eastern Ethiopia: the need for antimicrobial stewardship. Hosp Pharm. 2018;53(1):44–54.
17.
McCaguePMcElnayJDonnellyR. What are your views on specials and extemporaneous medicines preparation?Stroke. 2018;13:57.
18.
PaiVNahataM. Need for extemporaneous formulations in pediatric patients. J Pediatr Pharmacol Ther. 2001;6:107–121.
19.
PawarSKumarA. Issues in the formulation of drugs for oral use in children. Paediatr Drugs. 2002;4(6):371–379.
20.
ShankarPUpadhyayDSubishPDubeyAMishraP. Prescribing patterns among paediatric inpatients in a teaching hospital in western Nepal. Singapore Med J. 2006;47(4):261.
21.
BreitkreutzJBoosJ. Paediatric and geriatric drug delivery. Expert Opin Drug Deliv. 2007;4(1):37–45.
22.
QindeelSKashifM. The state of children in Pakistan2015.
23.
World Health Organization. Framework for Health Information Systems and Core Indicators for Monitoring Health Situation and Health System Performance2016. Geneva: World Health Organization; 2016.
24.
Tasawer BaigMAkbar SialAHumaAAhmedMShahidUSyedN. Irrational antibiotic prescribing practice among children in critical care of tertiary hospitals. Pak J Pharm Sci. 2017;30(4)(suppl):1483–1489.
25.
KhanIAHasnainFYasoobMQamarSChaudryKHussainM. Use of antibiotics within the Integrated Management of Childhood Illness (IMCI): guidelines in pediatric outpatient settings. Paper presented at: APMC2016.
26.
AberaBKibretMMuluW. Knowledge and beliefs on antimicrobial resistance among physicians and nurses in hospitals in Amhara Region, Ethiopia. BMC Pharmacol Toxicol. 2014;15(1):26.
27.
ChangJYeDLvB. Sale of antibiotics without a prescription at community pharmacies in urban China: a multicentre cross-sectional survey. J Antimicrob Chemother. 2017;72(4):1235–1242.
28.
AtifMAzeemMSarwarMR. WHO/INRUD prescribing indicators and prescribing trends of antibiotics in the Accident and Emergency Department of Bahawal Victoria Hospital, Pakistan. SpringerPlus. 2016;5(1):1928.
29.
EssackSBellJShephardA. Community pharmacists—leaders for antibiotic stewardship in respiratory tract infection. J Clin Pharm Ther. 2018;43(2):302–307.
30.
MasonTTrochezCThomasRBabarMHessoIKayyaliR. Knowledge and awareness of the general public and perception of pharmacists about antibiotic resistance. BMC Public Health. 2018;18(1):711.
31.
AliIKhanTM. Potential for community pharmacies to promote rational drug use in Pakistan. Res Social Adm Pharm. 2016;12(1):167–168.
32.
AtifMAhmadMSaleemQCurleyLQamar-uz-ZamanMBabarZ-U-D. Pharmaceutical policy in Pakistan. In: BabarZ-U-D, ed. Pharmaceutical Policy in Countries with Developing Healthcare Systems. Cham: Springer International Publishing; 2017:25–44.
33.
AtifMAzeemMSarwarMR. Evaluation of prescription errors and prescribing indicators in the private practices in Bahawalpur, Pakistan. J Chin Med Assoc. 2018;81(5):444–449.
34.
Pakistan Bureau of Statistics. Province wise provisional results of census—2017. Islamabad: Pakistan Bureau of Statistics, 2017.
35.
Paediatric Formulary Committee. British National Formulary for Children (BNFC). London: Pharmaceutical Press; 2016-2017. http://www.medicinescomplete.com. Accessed December 25, 2018.
36.
QureshiYDayoAGhotoM. Evaluation of prescriptions containing antibiotics in pediatrics, suffering from respiratory tract infections at selected Hospitals of Jamshoro and Hyderabad, Pakistan. B55 Pediatr Clin Stud. 2018;197:A3656.
MukherjeeSSahaN. Correlation of recommendations of treatment guidelines and frequently prescribed antibiotics: evaluation of their pharmaceutical pack size. Basic Clin Pharmacol Toxicol. 2017;122(3):317–321.
CameronAEwenMRoss-DegnanDBallDLaingR. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240–249.
41.
ChenWTangSSunJRoss-DegnanDWagnerAK. Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces. BMC Health Serv Res. 2010;10(1):211.
42.
Le DoareKBarkerCIIrwinASharlandM. Improving antibiotic prescribing for children in the resource-poor setting. Br J Clin Pharmacol. 2015;79(3):446–455.
43.
DuncanJCOrubuSTuleuCTurnerMNunnAJ. Age-appropriate evaluation and availability of enteral drug formulations in WHO essential medicines list for children. Paper presented at: 4th Conference of the European Paediatric Formulation Initiative (EuPFI); 2012; Prague.
44.
BatchelorHKMarriottJF. Formulations for children: problems and solutions. Br J Clin Pharmacol. 2015;79(3):405–418.
45.
VenablesRMarriottJStirlingH. FIND OUT: key problems with children’s medicines formulations…It’s a taste issue. Int J Pharm Pract. 2012;20(suppl 2):23.
46.
KaramikhahRFirouzabadiDBahmaniSVazinA. Cost estimation related to drug waste in two major pediatric referral centers and one adult hospital in southern Iran: comparative cross-sectional study. Trends Pharma Sci. 2018;4(1).
47.
NepalGBhattaS. Self-medication with antibiotics in WHO Southeast Asian Region: a systematic review. Cureus. 2018;10(4):e2428.
48.
OkekeINAdebayoL. Export of antimicrobial drugs by West African Travelers. J Travel Med. 2003;10(2):133–135.
49.
ParimiNPinto PereiraLMPrabhakarP. The general public’s perceptions and use of antimicrobials in Trinidad and Tobago. Rev Panam Salud Publica. 2002;12(1):11–18.
50.
DesaiAJGayathriGMehtaD. Public’s perception, knowledge, attitude and behaviour on antibiotic resistance—a survey in Davangere City, India. J Prev Med Holistic Health. 2016;2(1):17–23.
51.
CampbellGAVallejoE. Primary packaging considerations in developing medicines for children: oral liquid and powder for constitution. J Pharma Sci. 2015;104(1):52–62.
52.
JassimAM.In-home drug storage and self-medication with antimicrobial drugs in Basrah, Iraq. Oman Med J. 2010;25(2):79.
53.
PeaceNOlubukolaOMoshoodA. Stability of reconstituted amoxicillin clavulanate potassium under simulated in-home storage conditions. J Appl Pharm Sci. 2012;2(1):28–31.
54.
RommanHAHA. Patterns of antibiotic use among children. Int J Med Sci. 2013;5(6):264–272.
55.
ChanGCTangSF. Parental knowledge, attitudes and antibiotic use for acute upper respiratory tract infection in children attending a primary healthcare clinic in Malaysia. Singapore Med J. 2006;47(4):266–270.
56.
ChavesCMPBezerraCMLimaFETCardosoMVLMLFonsecaSGDCSilvaVMD. Residual volume in vials of antibiotics used in pediatrics. Rev Esc Enferm USP. 2017;51:e03234.
57.
KorenGBarzilayZGreenwaldM. Tenfold errors in administration of drug doses: a neglected iatrogenic disease in pediatrics. Pediatrics. 1986;77(6):848–849.
58.
TaufiqMZuberiRW. Overuse of antibiotics in children for upper respiratory infections (URIs): a dilemma. J Coll Physicians Surg Pak. 2011;21(1):60.
59.
IftikharSSarwarMRSaqibASarfrazM. Antibiotic prescribing practices and errors among hospitalized pediatric patients suffering from acute respiratory tract infections: a multicenter, cross-sectional study in Pakistan. Medicina. 2019;55(2):44.
60.
Medication errors cause half a million deaths in Pakistan, say pharmacists. Dawn, October11, 2017.
61.
KozerE. Medication errors in children. Paediatr Drugs. 2009;11(1):52–54.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
